UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 84 WEEKS FROM THE SELECT-MONOTHERAPY STUDY

被引：3

作者：

Smolen, J. S. ^{[1
]}

Emery, P. ^{[2
,3
]}

Rigby, W. ^{[4
]}

Tanaka, Y. ^{[5
]}

Vargas, J. Ignacio ^{[6
]}

Damjanov, N. ^{[7
]}

Jain, M. ^{[8
]}

Song, Y. ^{[9
]}

Khan, N. ^{[9
]}

Enejosa, J. J. ^{[9
]}

Cohen, S. B. ^{[10
]}

机构：

[1] Med Univ Vienna, Vienna, Austria

[2] Univ Leeds, Leeds, W Yorkshire, England

[3] NIHR Biomed Res Ctr, Leeds, W Yorkshire, England

[4] Dartmouth Coll, Hanover, NH 03755 USA

[5] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan

[6] Quantum Res, Puerto Varas, Chile

[7] Univ Belgrade, Inst Rheumatol, Sch Med, Belgrade, Serbia

[8] Great Lakes Clin Trials, Chicago, IL USA

[9] AbbVie Inc, N Chicago, IL USA

[10] Metroplex Clin Res Ctr, Dallas, TX USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷

关键词：

D O I：

10.1136/annrheumdis-2020-eular.961

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0213

引用

页码：327 / 328

页数：2

共 50 条

[1] UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE TO METHOTREXATE: RESULTS AT 260 WEEKS FROM THE SELECT-MONOTHERAPY STUDY
Smolen, J. S.
Emery, P.
Rigby, W.
Tanaka, Y.
Vargas, J. Ignacio
Damjanov, N.
Jain, M.
Kato, K.
Carter, K.
Khan, N.
Camp, H.
Cohen, S. B.
ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 723 - 724
[2] Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis and Prior Inadequate Response to Methotrexate: Results at 84 Weeks
Smolen, Josef
Emery, Paul
Rigby, William
Tanaka, Yoshiya
Vargas, Juan
Damjanov, Nemanja
Jain, Manish
Song, Yanna
Khan, Nasser
Enejosa, Jeffrey
Cohen, Stanley
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[3] UPADACITINIB AS MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 48 WEEKS FROM THE SELECT-MONOTHERAPY STUDY
Smolen, Josef S.
Emery, Paul
Rigby, William
Tanaka, Yoshiya
Ignacio Vargas, Juan
Damjanov, Nemanja
Jain, Manish
Sui, Yunxia
Enejosa, Jeffrey
Pangan, Aileen
Camp, Heidi
Cohen, Stanley B.
ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 371 - 372
[4] Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study
Smolen, Josef S.
Pangan, Aileen L.
Emery, Paul
Rigby, William
Tanaka, Yoshiya
Vargas, Juan Ignacio
Zhang, Ying
Damjanov, Nemanja
Friedman, Alan
Othman, Ahmed A.
Camp, Heidi S.
Cohen, Stanley
LANCET, 2019, 393 (10188): : 2303 - 2311
[5] Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY
Strand, Vibeke
Tundia, Namita
Wells, Alvin
Buch, Maya H.
Radominski, Sebastiao C.
Camp, Heidi S.
Friedman, Alan
Suboticki, Jessica L.
Dunlap, Kendall
Goldschmidt, Debbie
Bergman, Martin
RHEUMATOLOGY, 2021, 60 (07) : 3209 - 3221
[6] UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS FROM SELECT-EARLY
Van Vollenhoven, R.
Takeuchi, T.
Rischmueller, M.
Blanco, R.
Xavier, R.
Howard, M.
Friedman, A.
Song, Y.
Strand, V.
ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 330 - 331
[7] UPADACITINIB MONOTHERAPY IN METHOTREXATE-NAIVE PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS AT 72 WEEKS
Rischmueller, Maureen
Takeuchi, Tsutomu
Rischmueller, Maureen
Blanco, Ricardo
Xavier, Ricardo
Howard, Mark
Friedman, Alan
Song, Yanna
Strand, Vibeke
INTERNAL MEDICINE JOURNAL, 2021, 51 : 47 - 47
[8] Upadacitinib Monotherapy in Methotrexate-naive Patients with Rheumatoid Arthritis: Results at 72 Weeks
van Vollenhoven, Ronald
Takeuchi, Tsutomu
Rischmueller, Maureen
Blanco, Ricardo
Xavier, Ricardo
Howard, Mark
Friedman, Alan
Song, Yanna
Strand, Vibeke
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[9] Upadacitinib as Monotherapy in Patients with Rheumatoid Arthritis: Results at 48 Weeks
Smolen, Josef
Emery, Paul
Rigby, William
Tanaka, Yoshiya
Ignacio Vargas, Juan
Damjanov, Nemanja
Jain, Manish
Sui, Yunxia
Enejosa, Jose Jeff Rey
Pangan, Aileen
Camp, Heidi
Cohen, Stanley
ARTHRITIS & RHEUMATOLOGY, 2019, 71
[10] Upadacitinib as monotherapy in patients with active rheumatoid arthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study (vol 393, pg 2303, 2019)
Smolen, J. S.
Pangan, A. L.
Emery, P.
LANCET, 2019, 393 (10191): : 2590 - 2590

← 1 2 3 4 5 →